Portal Circulation
Oral
Intravenous
Intramuscular
Rectal
Subcutaneous
Sublingual
Topical
Inhalation
Transdermal
Intrathecal
PCA (Patient-Controlled Analgesia)
50% first-pass metabolism
Rapid and sustained effect
Important Concepts
First-Pass Metabolism: Some routes (like oral) undergo significant metabolism in the liver before reaching systemic circulation.
Local Effects: Topical and intrathecal routes provide targeted effects.
Key Considerations
Cause of Pain: Understand underlying issues.
Treatment Options: Evaluate risks vs. benefits.
Synergy: Use combinations for enhanced efficacy.
Monitoring: Efficacy and side effects.
Adjunct Treatments: Evaluate complementary therapies.
Definition: Interaction of two or more drugs resulting in a greater combined effect than the sum of their individual effects.
Example Medications:
Peripheral Treatments: NSAIDs and glucocorticoids show high efficacy in inflammation.
CNS Treatments: Opioids are potent – assess using mg or mcg dosages.
Acetaminophen: Serves as an analgesic but lacks anti-inflammatory properties.
Patient Profile: 30-year-old with a fractured right arm, presenting acute pain.
Observations:
SOB: Shortness of breath assessed.
Skin Assessment: Significant findings noted (analyze appearance).
Vital Signs:
HR: 100 bpm
RR: 16
BP: 148/88
Temp: 36.8C
No nausea/vomiting (N&V).
Use in Pain Management: First choice for various conditions due to safety in pediatrics and pregnancy.
MOA: Acts by inducing hypothalamic-peripheral vasodilation, promoting heat loss.
Comparative Options:
NSAIDs (Ibuprofen): Anti-inflammatories reducing cytokines.
No ASA in Pediatrics: Safety concerns with aspirin in children.
Mechanisms:
Hypothalamic Response: Reacts to pyrogens (bacterial/endogenous).
Goals of Management: Comfort, decrease BMR, optimize cellular function.
Used medications: Acetaminophen and NSAIDs for symptomatic control.
Precautions: Always check drug combinations for active ingredient content:
Allergy-related: Antihistamines (e.g., diphenhydramine).
Cough: Antitussives (e.g., Codeine, Dextromethorphan) can cause CNS depression.
Congestion: Adrenergic agonists (e.g., Ephedrine, Pseudoephedrine) reduce nasal secretions.
Functionality: A protective mechanism involving stimulation of receptors; communicated via nervous impulses to induce the cough action.
Challenges Identified:
Healthcare Professionals: Education and approach to pain management.
Patients: Fear of addiction impacts treatment willingness.
Euphoria: Psychological aspect characterized by:
Cravings
Compulsive Use
Loss of Control
Consequences of Use
Reference material link provided (YouTube).
Acute Pain (< 10 Days): Self-limiting, responds to treatment; SNS responses active.
Chronic Pain (> 6 Months):
Often a result of poorly managed acute pain; involves neurogenic inflammation.
Symptoms persist, causing various dysfunctions (e.g., anxiety, insomnia).
Management Strategies:
Combine treatment modalities including cognitive-behavioral therapy, physiotherapy, and CNS drugs.
Opioids considered but not first-line for chronic pain.
Influenced by repetitive SNS activity leading to chronic inflammation.
Condition Examples:
CRPS (Complex Regional Pain Syndrome): Symptoms include allodynia and skin changes.
Underlying Diagnosis: Important in tailoring appropriate treatment plans.
Options: Pain clinics, counseling (CBT), physiotherapy, CNS drugs targeting neurotransmitter modulation.
Drugs of Note: Gabapentin, NMDA antagonists.